Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay CTA Index +0.09% in July on weakened dollar (-0.91% YTD)

Wednesday, August 18, 2010
Opalesque Industry Update - Managed futures gained 0.09% in July according to the Barclay CTA Index compiled by BarclayHedge. Year-to-date, the Barclay CTA Index has lost 0.91%.

“As market participants moved from a risk-avoidance posture to a more risk-seeking strategy in July, many traders were caught on the wrong side of a rally in global commodities,” says Sol Waksman, founder and president of BarclayHedge.

“Even with the negative impact of commodity losses on portfolio returns, July provided its fair share of profitable trades for CTAs.”

“The rally in wheat amid fears of shortages in Russia captured the attention of the press and drove prices 30 percent higher. If you got the wheat trade right, then it was a very good month.”

Six of Barclay’s eight managed futures indices had a positive return in July. Currency Traders gained 0.64%, Discretionary Traders were up 0.52%, Agricultural Traders gained 0.51%, and Financial & Metals Traders rose 0.31%. “The continuing rally in bond prices and an across-the-board weakening of the US Dollar against G-10 currencies during July provided profitable trend trading opportunities for portfolios invested in those sectors, ” says Waksman. The Diversified Traders Index lost 0.17% in July. The Barclay BTOP50 Index, which monitors performance of the largest traders, was down 0.77% in July.

Source

kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its